Buy Veru Stock | FHCO Stock Price & Latest News | Public
FHCO

Veru

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About FHCO

    Veru, Inc. is an oncology and urology biopharmaceutical company. It develops medicines for prostate cancer treatment and prostate cancer supportive care as well as urology specialty pharmaceuticals. Its oncology drug candidates includes VERU-111, an oral alpha and beta ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$216,57M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.74
    1 Year Low$2.09
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app